| Filed On | Filing |
|---|---|
| 16 Feb 2016 |
Form 5: Burns Thomas M., VP, Finance & Chief Financial
Acquired 6,541 shares (Other Transaction) ($9K) |
| 16 Feb 2016 |
Form 5: Neal James R, VP Business Development
Acquired 1,775 shares (Other Transaction) ($6.14K) · Acquired 703 shares (Other Transaction) ($2.59K) · Acquired 4,318 shares (Other Transaction) ($4.88K) · 1 more |
| 16 Feb 2016 |
Form 5: Rubin Paul D, Sr. VP Clinical Dev. & CMO
Acquired 1,457 shares (Other Transaction) ($5.04K) · Acquired 575 shares (Other Transaction) ($2.12K) · Acquired 6,541 shares (Other Transaction) ($9K) |
| 16 Feb 2016 |
Form 5: Scannon Patrick J Md Phd, Director
Acquired 8,721 shares (Other Transaction) ($12K) |
| 16 Feb 2016 |
Form 5: Varian John, Director
Acquired 8,721 shares (Other Transaction) ($12K) |
| 17 Feb 2015 |
Form 5: Kurland Fred, CFO & VP Finance
Acquired 3,001 shares (Other Transaction) ($11.5K) |
| 17 Feb 2015 |
Form 5: Scannon Patrick J Md Phd, Director
Acquired 3,001 shares (Other Transaction) ($11.5K) |
| 17 Feb 2015 |
Form 5: Varian John, Director
Acquired 3,001 shares (Other Transaction) ($11.5K) |
| 17 Feb 2015 |
Form 5: Klein Thomas, Chief Commercial Officer
Acquired 3,001 shares (Other Transaction) ($11.5K) |
| 17 Feb 2015 |
Form 5: Neal James R, VP Business Development
Acquired 1,229 shares (Other Transaction) ($6.08K) · Acquired 594 shares (Other Transaction) ($2.59K) · Acquired 647 shares (Other Transaction) ($2.59K) · 1 more |
| 17 Feb 2015 |
Form 5: Rubin Paul D, Sr. VP Clinical Dev. & CMO
Acquired 306 shares (Other Transaction) ($1.96K) · Acquired 1,114 shares (Other Transaction) ($5.51K) · Acquired 472 shares (Other Transaction) ($2.06K) · 2 more |
| 14 Feb 2014 |
Form 5: Kurland Fred, CFO & VP Finance
Disposed of 254 shares (Other Transaction) · Acquired 1,994 shares (Other Transaction) |
| 14 Feb 2014 |
Form 5: Scannon Patrick J Md Phd, Director
Acquired 1,740 shares (Other Transaction) ($11.5K) |
| 14 Feb 2014 |
Form 5: Varian John, Director
Acquired 1,740 shares (Other Transaction) ($11.5K) |
| 14 Feb 2014 |
Form 5: Klein Thomas, Chief Commercial Officer
Acquired 1,659 shares (Other Transaction) ($11K) |
| 14 Feb 2014 |
Form 5: Rubin Paul D, Sr. VP Clinical Dev. & CMO
Acquired 888 shares (Other Transaction) ($5.87K) |
| 13 Feb 2013 |
Form 5: Varian John, Director
Acquired 4,455 shares (Other Transaction) ($11.2K) |
| 13 Feb 2013 |
Form 5: Scannon Patrick J Md Phd, Director
Acquired 4,455 shares (Other Transaction) ($11.2K) |
| 13 Feb 2013 |
Form 5: Rubin Paul D, Sr. VP Clinical Dev. & CMO
Acquired 2,214 shares (Other Transaction) ($5.59K) |
| 13 Feb 2013 |
Form 5: Kurland Fred, CFO & VP Finance
Acquired 4,455 shares (Other Transaction) ($11.2K) |
Loading...